Changes in the Expression of TGF-Beta Regulatory Pathway Genes Induced by Vitamin D in Patients with Relapsing-Remitting Multiple Sclerosis.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
22 Sep 2023
Historique:
received: 19 07 2023
revised: 20 09 2023
accepted: 20 09 2023
medline: 2 11 2023
pubmed: 14 10 2023
entrez: 14 10 2023
Statut: epublish

Résumé

Vitamin D is an environmental factor related to multiple sclerosis that plays a significant role in immune regulation. TGF-β is a superfamily of cytokines with an important dual effect on the immune system. TGF-β inhibits the Th1 response while facilitating the preservation of regulatory T cells (FOXP3+) in an immunoregulatory capacity. However, when IL-6 is present, it stimulates the Th17 response. Our aim was to analyze the regulatory effect of vitamin D on the in vivo TGF-β signaling pathway in patients with relapsing-remitting multiple sclerosis (RRMS). A total of 21 patients with vitamin D levels < 30 ng/mL were recruited and supplemented with oral vitamin D. All patients were receiving disease-modifying therapy, with the majority being on natalizumab. Expression of

Identifiants

pubmed: 37833895
pii: ijms241914447
doi: 10.3390/ijms241914447
pmc: PMC10572771
pii:
doi:

Substances chimiques

Vitamin D 1406-16-2
Natalizumab 0
Vitamins 0
Transforming Growth Factor beta 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Instituto de Investigación Sanitaria Gregorio Marañón
ID : II-POSTMIR-2016

Références

Brain. 2010 Apr;133(Pt 4):1067-81
pubmed: 20354004
J Neurosci. 2008 Jan 9;28(2):434-46
pubmed: 18184786
FASEB J. 2001 Dec;15(14):2579-85
pubmed: 11726533
Brain Behav Immun. 2018 Feb;68:1-10
pubmed: 28249802
Eur J Immunol. 2010 Jan;40(1):142-52
pubmed: 19943263
J Neurobiol. 2000 Apr;43(1):1-17
pubmed: 10756062
Acta Neuropathol. 2015 May;129(5):625-37
pubmed: 25716179
Brain Behav. 2015 Sep;5(9):e00362
pubmed: 26445701
Neurology. 2016 Jan 26;86(4):382-90
pubmed: 26718578
Int Immunopharmacol. 2015 Sep;28(1):414-9
pubmed: 26188623
Int J Mol Sci. 2022 Aug 29;23(17):
pubmed: 36077185
Cell Tissue Res. 2012 Jan;347(1):21-36
pubmed: 21643690
J Neurol Sci. 2011 Dec 15;311(1-2):44-9
pubmed: 21620416
Neurotherapeutics. 2021 Jul;18(3):1798-1814
pubmed: 34159538
PLoS One. 2009 Aug 13;4(8):e6635
pubmed: 19675671
Trends Cell Biol. 2017 Sep;27(9):658-672
pubmed: 28552280
Ann Clin Transl Neurol. 2014 Aug;1(8):605-17
pubmed: 25285313
Int J Mol Sci. 2020 Jan 20;21(2):
pubmed: 31968593
Ann Neurol. 2006 Feb;59(2):344-52
pubmed: 16437558
Immunol Cell Biol. 2015 Aug;93(7):662-72
pubmed: 25823994
Nat Med. 2007 Oct;13(10):1173-5
pubmed: 17828272
CNS Drugs. 2019 Dec;33(12):1187-1199
pubmed: 31686407
J Autoimmun. 2017 Mar;78:57-69
pubmed: 28063629
Nutrients. 2022 Nov 09;14(22):
pubmed: 36432424
J Cell Sci. 2005 Aug 15;118(Pt 16):3573-84
pubmed: 16105881
JAMA Neurol. 2014 Mar;71(3):306-14
pubmed: 24445558
J Neurol Sci. 2015 Mar 15;350(1-2):18-23
pubmed: 25680585
J Neurosci Res. 2008 Jan;86(1):125-35
pubmed: 17722066
J Neuroimmunol. 2011 Apr;233(1-2):240-4
pubmed: 21186064
Neurochem Int. 2011 Oct;59(5):542-50
pubmed: 21718734
Nature. 2006 May 11;441(7090):231-4
pubmed: 16648837
Int J Dev Neurosci. 2001 Apr;19(2):219-27
pubmed: 11255035
Acta Neurol Scand. 2015;132(199):56-61
pubmed: 26046560
F1000Prime Rep. 2014 Dec 01;6:118
pubmed: 25580272
Life Sci. 2015 Aug 1;134:63-7
pubmed: 26037400
Int J Mol Sci. 2017 Apr 29;18(5):
pubmed: 28468254
J Neuroimmunol. 2020 Oct 15;347:577358
pubmed: 32795734
Am J Pathol. 2019 Mar;189(3):665-676
pubmed: 30553833
J Biol Chem. 2015 May 8;290(19):12222-36
pubmed: 25809484
Physiol Rev. 2016 Jan;96(1):365-408
pubmed: 26681795
Pharmacogenomics J. 2018 Jan;18(1):98-105
pubmed: 27670768
Neuropharmacology. 2009 May-Jun;56(6-7):929-36
pubmed: 19285095
Lancet Neurol. 2015 Apr;14(4):406-19
pubmed: 25792099
J Neuroimmunol. 2011 Jan;230(1-2):164-8
pubmed: 21093933
Mult Scler. 2009 Jul;15(7):848-53
pubmed: 19542263
J Neuroimmunol. 2017 Sep 15;310:120-128
pubmed: 28778435
J Neurosci. 1997 Jun 1;17(11):4112-20
pubmed: 9151728
J Biol Chem. 2006 Aug 18;281(33):23748-56
pubmed: 16777850
Cold Spring Harb Perspect Biol. 2017 Feb 1;9(2):
pubmed: 27864313
Mult Scler. 2013 Apr;19(5):605-12
pubmed: 23012253
Neurology. 2019 Nov 12;93(20):e1906-e1916
pubmed: 31594857
J Neuroimmunol. 2013 Nov 15;264(1-2):91-9
pubmed: 24080309
Neurol Neuroimmunol Neuroinflamm. 2019 Aug 6;6(5):
pubmed: 31454777
Nat Rev Drug Discov. 2012 Oct;11(10):790-811
pubmed: 23000686
Front Immunol. 2020 Sep 24;11:549842
pubmed: 33072089
Cell Signal. 2013 Oct;25(10):2017-24
pubmed: 23770288

Auteurs

Alberto Lozano-Ros (A)

Servicio de Neurología, Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.

María L Martínez-Ginés (ML)

Servicio de Neurología, Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.

José M García-Domínguez (JM)

Servicio de Neurología, Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.

Sara Salvador-Martín (S)

Servicio de Farmacia, Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.

Haydee Goicochea-Briceño (H)

Servicio de Neurología, Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.

Juan P Cuello (JP)

Servicio de Neurología, Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.

Ariana Meldaña-Rivera (A)

Servicio de Neurología, Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.

Yolanda Higueras-Hernández (Y)

Servicio de Neurología, Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.

María Sanjurjo-Sáez (M)

Servicio de Farmacia, Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.

Luis A Álvarez-Sala-Walther (LA)

Servicio de Medicina Interna, Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.

Luis A López-Fernández (LA)

Servicio de Farmacia, Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH